Medical Devices & Consumables
Global Vaccine Microarray Patches (VMAPs) Market Research Report 2026
- Jan 17, 26
- ID: 686914
- Pages: 124
- Figures: 126
- Views: 1
This report delivers a comprehensive overview of the global Vaccine Microarray Patches (VMAPs) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Vaccine Microarray Patches (VMAPs). The Vaccine Microarray Patches (VMAPs) market size, estimates, and forecasts are provided in terms of sales volume (K Pcs) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Vaccine Microarray Patches (VMAPs) market comprehensively. Regional market sizes by Type, by Application, by Microneedle Material, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Vaccine Microarray Patches (VMAPs) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Kindeva
Raphas
CosMED Pharmaceutical
Vaxess Technologies
Micron Biomedical
LTS Lohmann Therapie-Systeme
ArrayPatch
CeraVx
Zhongke Microneedle (Beijing) Technology
Zhuhai Youwe Biotechnology
Youwei (Zhuhai) Biotechnology
WCC Biomedical
Hisamitsu Pharmaceutical
Segment by Type
Dissolving
Non-dissolving
Segment by Microneedle Material
Hyaluronic Acid
Taurine
Triple-helical Collagen
Segment by Form of Use
Patches
Direct Topical
by Application
Routine Childhood Immunization
Adolescent / Pre-adolescent Prevention
Travel / Endemic Exposure / Post-exposure
Respiratory Vaccines with Recurring Demand
Outbreak / Pandemic Preparedness
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Microneedle Material, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Vaccine Microarray Patches (VMAPs) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Vaccine Microarray Patches (VMAPs) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Vaccine Microarray Patches (VMAPs) market comprehensively. Regional market sizes by Type, by Application, by Microneedle Material, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Vaccine Microarray Patches (VMAPs) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Kindeva
Raphas
CosMED Pharmaceutical
Vaxess Technologies
Micron Biomedical
LTS Lohmann Therapie-Systeme
ArrayPatch
CeraVx
Zhongke Microneedle (Beijing) Technology
Zhuhai Youwe Biotechnology
Youwei (Zhuhai) Biotechnology
WCC Biomedical
Hisamitsu Pharmaceutical
Segment by Type
Dissolving
Non-dissolving
Segment by Microneedle Material
Hyaluronic Acid
Taurine
Triple-helical Collagen
Segment by Form of Use
Patches
Direct Topical
by Application
Routine Childhood Immunization
Adolescent / Pre-adolescent Prevention
Travel / Endemic Exposure / Post-exposure
Respiratory Vaccines with Recurring Demand
Outbreak / Pandemic Preparedness
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Microneedle Material, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Vaccine Microarray Patches (VMAPs) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Vaccine Microarray Patches (VMAPs) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Vaccine Microarray Patches (VMAPs) Market Overview
1.1 Product Definition
1.2 Vaccine Microarray Patches (VMAPs) by Type
1.2.1 Global Vaccine Microarray Patches (VMAPs) Market Value by Type: 2025 vs 2032
1.2.2 Dissolving
1.2.3 Non-dissolving
1.3 Vaccine Microarray Patches (VMAPs) by Microneedle Material
1.3.1 Global Vaccine Microarray Patches (VMAPs) Market Value by Microneedle Material: 2025 vs 2032
1.3.2 Hyaluronic Acid
1.3.3 Taurine
1.3.4 Triple-helical Collagen
1.4 Vaccine Microarray Patches (VMAPs) by Form of Use
1.4.1 Global Vaccine Microarray Patches (VMAPs) Market Value by Form of Use: 2025 vs 2032
1.4.2 Patches
1.4.3 Direct Topical
1.5 Vaccine Microarray Patches (VMAPs) by Application
1.5.1 Global Vaccine Microarray Patches (VMAPs) Market Value by Application: 2025 vs 2032
1.5.2 Routine Childhood Immunization
1.5.3 Adolescent / Pre-adolescent Prevention
1.5.4 Travel / Endemic Exposure / Post-exposure
1.5.5 Respiratory Vaccines with Recurring Demand
1.5.6 Outbreak / Pandemic Preparedness
1.6 Global Vaccine Microarray Patches (VMAPs) Market Size Estimates and Forecasts
1.6.1 Global Vaccine Microarray Patches (VMAPs) Revenue 2021–2032
1.6.2 Global Vaccine Microarray Patches (VMAPs) Sales 2021–2032
1.6.3 Global Vaccine Microarray Patches (VMAPs) Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Vaccine Microarray Patches (VMAPs) Market Competition by Manufacturers
2.1 Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Vaccine Microarray Patches (VMAPs) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Vaccine Microarray Patches (VMAPs) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Vaccine Microarray Patches (VMAPs), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Vaccine Microarray Patches (VMAPs), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Vaccine Microarray Patches (VMAPs), Product Types and Applications
2.7 Global Key Manufacturers of Vaccine Microarray Patches (VMAPs), Date of Entry into the Industry
2.8 Global Vaccine Microarray Patches (VMAPs) Market Competitive Situation and Trends
2.8.1 Global Vaccine Microarray Patches (VMAPs) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Vaccine Microarray Patches (VMAPs) Players Market Share by Revenue
2.8.3 Global Vaccine Microarray Patches (VMAPs) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vaccine Microarray Patches (VMAPs) Market Scenario by Region
3.1 Global Vaccine Microarray Patches (VMAPs) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Vaccine Microarray Patches (VMAPs) Sales by Region: 2021–2032
3.2.1 Global Vaccine Microarray Patches (VMAPs) Sales by Region: 2021–2026
3.2.2 Global Vaccine Microarray Patches (VMAPs) Sales by Region: 2027–2032
3.3 Global Vaccine Microarray Patches (VMAPs) Revenue by Region: 2021–2032
3.3.1 Global Vaccine Microarray Patches (VMAPs) Revenue by Region: 2021–2026
3.3.2 Global Vaccine Microarray Patches (VMAPs) Revenue by Region: 2027–2032
3.4 North America Vaccine Microarray Patches (VMAPs) Market Facts & Figures by Country
3.4.1 North America Vaccine Microarray Patches (VMAPs) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Vaccine Microarray Patches (VMAPs) Sales by Country (2021–2032)
3.4.3 North America Vaccine Microarray Patches (VMAPs) Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vaccine Microarray Patches (VMAPs) Market Facts & Figures by Country
3.5.1 Europe Vaccine Microarray Patches (VMAPs) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Vaccine Microarray Patches (VMAPs) Sales by Country (2021–2032)
3.5.3 Europe Vaccine Microarray Patches (VMAPs) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccine Microarray Patches (VMAPs) Market Facts & Figures by Region
3.6.1 Asia Pacific Vaccine Microarray Patches (VMAPs) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Vaccine Microarray Patches (VMAPs) Sales by Region (2021–2032)
3.6.3 Asia Pacific Vaccine Microarray Patches (VMAPs) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Vaccine Microarray Patches (VMAPs) Market Facts & Figures by Country
3.7.1 Latin America Vaccine Microarray Patches (VMAPs) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Vaccine Microarray Patches (VMAPs) Sales by Country (2021–2032)
3.7.3 Latin America Vaccine Microarray Patches (VMAPs) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Vaccine Microarray Patches (VMAPs) Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccine Microarray Patches (VMAPs) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Vaccine Microarray Patches (VMAPs) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Vaccine Microarray Patches (VMAPs) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccine Microarray Patches (VMAPs) Sales by Type (2021–2032)
4.1.1 Global Vaccine Microarray Patches (VMAPs) Sales by Type (2021–2026)
4.1.2 Global Vaccine Microarray Patches (VMAPs) Sales by Type (2027–2032)
4.1.3 Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Type (2021–2032)
4.2 Global Vaccine Microarray Patches (VMAPs) Revenue by Type (2021–2032)
4.2.1 Global Vaccine Microarray Patches (VMAPs) Revenue by Type (2021–2026)
4.2.2 Global Vaccine Microarray Patches (VMAPs) Revenue by Type (2027–2032)
4.2.3 Global Vaccine Microarray Patches (VMAPs) Revenue Market Share by Type (2021–2032)
4.3 Global Vaccine Microarray Patches (VMAPs) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Vaccine Microarray Patches (VMAPs) Sales by Application (2021–2032)
5.1.1 Global Vaccine Microarray Patches (VMAPs) Sales by Application (2021–2026)
5.1.2 Global Vaccine Microarray Patches (VMAPs) Sales by Application (2027–2032)
5.1.3 Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Application (2021–2032)
5.2 Global Vaccine Microarray Patches (VMAPs) Revenue by Application (2021–2032)
5.2.1 Global Vaccine Microarray Patches (VMAPs) Revenue by Application (2021–2026)
5.2.2 Global Vaccine Microarray Patches (VMAPs) Revenue by Application (2027–2032)
5.2.3 Global Vaccine Microarray Patches (VMAPs) Revenue Market Share by Application (2021–2032)
5.3 Global Vaccine Microarray Patches (VMAPs) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Kindeva
6.1.1 Kindeva Company Information
6.1.2 Kindeva Description and Business Overview
6.1.3 Kindeva Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Kindeva Vaccine Microarray Patches (VMAPs) Product Portfolio
6.1.5 Kindeva Recent Developments/Updates
6.2 Raphas
6.2.1 Raphas Company Information
6.2.2 Raphas Description and Business Overview
6.2.3 Raphas Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Raphas Vaccine Microarray Patches (VMAPs) Product Portfolio
6.2.5 Raphas Recent Developments/Updates
6.3 CosMED Pharmaceutical
6.3.1 CosMED Pharmaceutical Company Information
6.3.2 CosMED Pharmaceutical Description and Business Overview
6.3.3 CosMED Pharmaceutical Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 CosMED Pharmaceutical Vaccine Microarray Patches (VMAPs) Product Portfolio
6.3.5 CosMED Pharmaceutical Recent Developments/Updates
6.4 Vaxess Technologies
6.4.1 Vaxess Technologies Company Information
6.4.2 Vaxess Technologies Description and Business Overview
6.4.3 Vaxess Technologies Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Vaxess Technologies Vaccine Microarray Patches (VMAPs) Product Portfolio
6.4.5 Vaxess Technologies Recent Developments/Updates
6.5 Micron Biomedical
6.5.1 Micron Biomedical Company Information
6.5.2 Micron Biomedical Description and Business Overview
6.5.3 Micron Biomedical Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Micron Biomedical Vaccine Microarray Patches (VMAPs) Product Portfolio
6.5.5 Micron Biomedical Recent Developments/Updates
6.6 LTS Lohmann Therapie-Systeme
6.6.1 LTS Lohmann Therapie-Systeme Company Information
6.6.2 LTS Lohmann Therapie-Systeme Description and Business Overview
6.6.3 LTS Lohmann Therapie-Systeme Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 LTS Lohmann Therapie-Systeme Vaccine Microarray Patches (VMAPs) Product Portfolio
6.6.5 LTS Lohmann Therapie-Systeme Recent Developments/Updates
6.7 ArrayPatch
6.7.1 ArrayPatch Company Information
6.7.2 ArrayPatch Description and Business Overview
6.7.3 ArrayPatch Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 ArrayPatch Vaccine Microarray Patches (VMAPs) Product Portfolio
6.7.5 ArrayPatch Recent Developments/Updates
6.8 CeraVx
6.8.1 CeraVx Company Information
6.8.2 CeraVx Description and Business Overview
6.8.3 CeraVx Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 CeraVx Vaccine Microarray Patches (VMAPs) Product Portfolio
6.8.5 CeraVx Recent Developments/Updates
6.9 Zhongke Microneedle (Beijing) Technology
6.9.1 Zhongke Microneedle (Beijing) Technology Company Information
6.9.2 Zhongke Microneedle (Beijing) Technology Description and Business Overview
6.9.3 Zhongke Microneedle (Beijing) Technology Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Zhongke Microneedle (Beijing) Technology Vaccine Microarray Patches (VMAPs) Product Portfolio
6.9.5 Zhongke Microneedle (Beijing) Technology Recent Developments/Updates
6.10 Zhuhai Youwe Biotechnology
6.10.1 Zhuhai Youwe Biotechnology Company Information
6.10.2 Zhuhai Youwe Biotechnology Description and Business Overview
6.10.3 Zhuhai Youwe Biotechnology Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Zhuhai Youwe Biotechnology Vaccine Microarray Patches (VMAPs) Product Portfolio
6.10.5 Zhuhai Youwe Biotechnology Recent Developments/Updates
6.11 Youwei (Zhuhai) Biotechnology
6.11.1 Youwei (Zhuhai) Biotechnology Company Information
6.11.2 Youwei (Zhuhai) Biotechnology Description and Business Overview
6.11.3 Youwei (Zhuhai) Biotechnology Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Youwei (Zhuhai) Biotechnology Vaccine Microarray Patches (VMAPs) Product Portfolio
6.11.5 Youwei (Zhuhai) Biotechnology Recent Developments/Updates
6.12 WCC Biomedical
6.12.1 WCC Biomedical Company Information
6.12.2 WCC Biomedical Description and Business Overview
6.12.3 WCC Biomedical Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 WCC Biomedical Vaccine Microarray Patches (VMAPs) Product Portfolio
6.12.5 WCC Biomedical Recent Developments/Updates
6.13 Hisamitsu Pharmaceutical
6.13.1 Hisamitsu Pharmaceutical Company Information
6.13.2 Hisamitsu Pharmaceutical Description and Business Overview
6.13.3 Hisamitsu Pharmaceutical Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Hisamitsu Pharmaceutical Vaccine Microarray Patches (VMAPs) Product Portfolio
6.13.5 Hisamitsu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccine Microarray Patches (VMAPs) Industry Chain Analysis
7.2 Vaccine Microarray Patches (VMAPs) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccine Microarray Patches (VMAPs) Production Mode & Process Analysis
7.4 Vaccine Microarray Patches (VMAPs) Sales and Marketing
7.4.1 Vaccine Microarray Patches (VMAPs) Sales Channels
7.4.2 Vaccine Microarray Patches (VMAPs) Distributors
7.5 Vaccine Microarray Patches (VMAPs) Customer Analysis
8 Vaccine Microarray Patches (VMAPs) Market Dynamics
8.1 Vaccine Microarray Patches (VMAPs) Industry Trends
8.2 Vaccine Microarray Patches (VMAPs) Market Drivers
8.3 Vaccine Microarray Patches (VMAPs) Market Challenges
8.4 Vaccine Microarray Patches (VMAPs) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Vaccine Microarray Patches (VMAPs) by Type
1.2.1 Global Vaccine Microarray Patches (VMAPs) Market Value by Type: 2025 vs 2032
1.2.2 Dissolving
1.2.3 Non-dissolving
1.3 Vaccine Microarray Patches (VMAPs) by Microneedle Material
1.3.1 Global Vaccine Microarray Patches (VMAPs) Market Value by Microneedle Material: 2025 vs 2032
1.3.2 Hyaluronic Acid
1.3.3 Taurine
1.3.4 Triple-helical Collagen
1.4 Vaccine Microarray Patches (VMAPs) by Form of Use
1.4.1 Global Vaccine Microarray Patches (VMAPs) Market Value by Form of Use: 2025 vs 2032
1.4.2 Patches
1.4.3 Direct Topical
1.5 Vaccine Microarray Patches (VMAPs) by Application
1.5.1 Global Vaccine Microarray Patches (VMAPs) Market Value by Application: 2025 vs 2032
1.5.2 Routine Childhood Immunization
1.5.3 Adolescent / Pre-adolescent Prevention
1.5.4 Travel / Endemic Exposure / Post-exposure
1.5.5 Respiratory Vaccines with Recurring Demand
1.5.6 Outbreak / Pandemic Preparedness
1.6 Global Vaccine Microarray Patches (VMAPs) Market Size Estimates and Forecasts
1.6.1 Global Vaccine Microarray Patches (VMAPs) Revenue 2021–2032
1.6.2 Global Vaccine Microarray Patches (VMAPs) Sales 2021–2032
1.6.3 Global Vaccine Microarray Patches (VMAPs) Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Vaccine Microarray Patches (VMAPs) Market Competition by Manufacturers
2.1 Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Vaccine Microarray Patches (VMAPs) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Vaccine Microarray Patches (VMAPs) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Vaccine Microarray Patches (VMAPs), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Vaccine Microarray Patches (VMAPs), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Vaccine Microarray Patches (VMAPs), Product Types and Applications
2.7 Global Key Manufacturers of Vaccine Microarray Patches (VMAPs), Date of Entry into the Industry
2.8 Global Vaccine Microarray Patches (VMAPs) Market Competitive Situation and Trends
2.8.1 Global Vaccine Microarray Patches (VMAPs) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Vaccine Microarray Patches (VMAPs) Players Market Share by Revenue
2.8.3 Global Vaccine Microarray Patches (VMAPs) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vaccine Microarray Patches (VMAPs) Market Scenario by Region
3.1 Global Vaccine Microarray Patches (VMAPs) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Vaccine Microarray Patches (VMAPs) Sales by Region: 2021–2032
3.2.1 Global Vaccine Microarray Patches (VMAPs) Sales by Region: 2021–2026
3.2.2 Global Vaccine Microarray Patches (VMAPs) Sales by Region: 2027–2032
3.3 Global Vaccine Microarray Patches (VMAPs) Revenue by Region: 2021–2032
3.3.1 Global Vaccine Microarray Patches (VMAPs) Revenue by Region: 2021–2026
3.3.2 Global Vaccine Microarray Patches (VMAPs) Revenue by Region: 2027–2032
3.4 North America Vaccine Microarray Patches (VMAPs) Market Facts & Figures by Country
3.4.1 North America Vaccine Microarray Patches (VMAPs) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Vaccine Microarray Patches (VMAPs) Sales by Country (2021–2032)
3.4.3 North America Vaccine Microarray Patches (VMAPs) Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vaccine Microarray Patches (VMAPs) Market Facts & Figures by Country
3.5.1 Europe Vaccine Microarray Patches (VMAPs) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Vaccine Microarray Patches (VMAPs) Sales by Country (2021–2032)
3.5.3 Europe Vaccine Microarray Patches (VMAPs) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccine Microarray Patches (VMAPs) Market Facts & Figures by Region
3.6.1 Asia Pacific Vaccine Microarray Patches (VMAPs) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Vaccine Microarray Patches (VMAPs) Sales by Region (2021–2032)
3.6.3 Asia Pacific Vaccine Microarray Patches (VMAPs) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Vaccine Microarray Patches (VMAPs) Market Facts & Figures by Country
3.7.1 Latin America Vaccine Microarray Patches (VMAPs) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Vaccine Microarray Patches (VMAPs) Sales by Country (2021–2032)
3.7.3 Latin America Vaccine Microarray Patches (VMAPs) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Vaccine Microarray Patches (VMAPs) Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccine Microarray Patches (VMAPs) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Vaccine Microarray Patches (VMAPs) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Vaccine Microarray Patches (VMAPs) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccine Microarray Patches (VMAPs) Sales by Type (2021–2032)
4.1.1 Global Vaccine Microarray Patches (VMAPs) Sales by Type (2021–2026)
4.1.2 Global Vaccine Microarray Patches (VMAPs) Sales by Type (2027–2032)
4.1.3 Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Type (2021–2032)
4.2 Global Vaccine Microarray Patches (VMAPs) Revenue by Type (2021–2032)
4.2.1 Global Vaccine Microarray Patches (VMAPs) Revenue by Type (2021–2026)
4.2.2 Global Vaccine Microarray Patches (VMAPs) Revenue by Type (2027–2032)
4.2.3 Global Vaccine Microarray Patches (VMAPs) Revenue Market Share by Type (2021–2032)
4.3 Global Vaccine Microarray Patches (VMAPs) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Vaccine Microarray Patches (VMAPs) Sales by Application (2021–2032)
5.1.1 Global Vaccine Microarray Patches (VMAPs) Sales by Application (2021–2026)
5.1.2 Global Vaccine Microarray Patches (VMAPs) Sales by Application (2027–2032)
5.1.3 Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Application (2021–2032)
5.2 Global Vaccine Microarray Patches (VMAPs) Revenue by Application (2021–2032)
5.2.1 Global Vaccine Microarray Patches (VMAPs) Revenue by Application (2021–2026)
5.2.2 Global Vaccine Microarray Patches (VMAPs) Revenue by Application (2027–2032)
5.2.3 Global Vaccine Microarray Patches (VMAPs) Revenue Market Share by Application (2021–2032)
5.3 Global Vaccine Microarray Patches (VMAPs) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Kindeva
6.1.1 Kindeva Company Information
6.1.2 Kindeva Description and Business Overview
6.1.3 Kindeva Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Kindeva Vaccine Microarray Patches (VMAPs) Product Portfolio
6.1.5 Kindeva Recent Developments/Updates
6.2 Raphas
6.2.1 Raphas Company Information
6.2.2 Raphas Description and Business Overview
6.2.3 Raphas Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Raphas Vaccine Microarray Patches (VMAPs) Product Portfolio
6.2.5 Raphas Recent Developments/Updates
6.3 CosMED Pharmaceutical
6.3.1 CosMED Pharmaceutical Company Information
6.3.2 CosMED Pharmaceutical Description and Business Overview
6.3.3 CosMED Pharmaceutical Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 CosMED Pharmaceutical Vaccine Microarray Patches (VMAPs) Product Portfolio
6.3.5 CosMED Pharmaceutical Recent Developments/Updates
6.4 Vaxess Technologies
6.4.1 Vaxess Technologies Company Information
6.4.2 Vaxess Technologies Description and Business Overview
6.4.3 Vaxess Technologies Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Vaxess Technologies Vaccine Microarray Patches (VMAPs) Product Portfolio
6.4.5 Vaxess Technologies Recent Developments/Updates
6.5 Micron Biomedical
6.5.1 Micron Biomedical Company Information
6.5.2 Micron Biomedical Description and Business Overview
6.5.3 Micron Biomedical Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Micron Biomedical Vaccine Microarray Patches (VMAPs) Product Portfolio
6.5.5 Micron Biomedical Recent Developments/Updates
6.6 LTS Lohmann Therapie-Systeme
6.6.1 LTS Lohmann Therapie-Systeme Company Information
6.6.2 LTS Lohmann Therapie-Systeme Description and Business Overview
6.6.3 LTS Lohmann Therapie-Systeme Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 LTS Lohmann Therapie-Systeme Vaccine Microarray Patches (VMAPs) Product Portfolio
6.6.5 LTS Lohmann Therapie-Systeme Recent Developments/Updates
6.7 ArrayPatch
6.7.1 ArrayPatch Company Information
6.7.2 ArrayPatch Description and Business Overview
6.7.3 ArrayPatch Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 ArrayPatch Vaccine Microarray Patches (VMAPs) Product Portfolio
6.7.5 ArrayPatch Recent Developments/Updates
6.8 CeraVx
6.8.1 CeraVx Company Information
6.8.2 CeraVx Description and Business Overview
6.8.3 CeraVx Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 CeraVx Vaccine Microarray Patches (VMAPs) Product Portfolio
6.8.5 CeraVx Recent Developments/Updates
6.9 Zhongke Microneedle (Beijing) Technology
6.9.1 Zhongke Microneedle (Beijing) Technology Company Information
6.9.2 Zhongke Microneedle (Beijing) Technology Description and Business Overview
6.9.3 Zhongke Microneedle (Beijing) Technology Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Zhongke Microneedle (Beijing) Technology Vaccine Microarray Patches (VMAPs) Product Portfolio
6.9.5 Zhongke Microneedle (Beijing) Technology Recent Developments/Updates
6.10 Zhuhai Youwe Biotechnology
6.10.1 Zhuhai Youwe Biotechnology Company Information
6.10.2 Zhuhai Youwe Biotechnology Description and Business Overview
6.10.3 Zhuhai Youwe Biotechnology Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Zhuhai Youwe Biotechnology Vaccine Microarray Patches (VMAPs) Product Portfolio
6.10.5 Zhuhai Youwe Biotechnology Recent Developments/Updates
6.11 Youwei (Zhuhai) Biotechnology
6.11.1 Youwei (Zhuhai) Biotechnology Company Information
6.11.2 Youwei (Zhuhai) Biotechnology Description and Business Overview
6.11.3 Youwei (Zhuhai) Biotechnology Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Youwei (Zhuhai) Biotechnology Vaccine Microarray Patches (VMAPs) Product Portfolio
6.11.5 Youwei (Zhuhai) Biotechnology Recent Developments/Updates
6.12 WCC Biomedical
6.12.1 WCC Biomedical Company Information
6.12.2 WCC Biomedical Description and Business Overview
6.12.3 WCC Biomedical Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 WCC Biomedical Vaccine Microarray Patches (VMAPs) Product Portfolio
6.12.5 WCC Biomedical Recent Developments/Updates
6.13 Hisamitsu Pharmaceutical
6.13.1 Hisamitsu Pharmaceutical Company Information
6.13.2 Hisamitsu Pharmaceutical Description and Business Overview
6.13.3 Hisamitsu Pharmaceutical Vaccine Microarray Patches (VMAPs) Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Hisamitsu Pharmaceutical Vaccine Microarray Patches (VMAPs) Product Portfolio
6.13.5 Hisamitsu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccine Microarray Patches (VMAPs) Industry Chain Analysis
7.2 Vaccine Microarray Patches (VMAPs) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccine Microarray Patches (VMAPs) Production Mode & Process Analysis
7.4 Vaccine Microarray Patches (VMAPs) Sales and Marketing
7.4.1 Vaccine Microarray Patches (VMAPs) Sales Channels
7.4.2 Vaccine Microarray Patches (VMAPs) Distributors
7.5 Vaccine Microarray Patches (VMAPs) Customer Analysis
8 Vaccine Microarray Patches (VMAPs) Market Dynamics
8.1 Vaccine Microarray Patches (VMAPs) Industry Trends
8.2 Vaccine Microarray Patches (VMAPs) Market Drivers
8.3 Vaccine Microarray Patches (VMAPs) Market Challenges
8.4 Vaccine Microarray Patches (VMAPs) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Vaccine Microarray Patches (VMAPs) Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Vaccine Microarray Patches (VMAPs) Market Value by Microneedle Material (US$ Million), 2025 vs 2032
Table 3. Global Vaccine Microarray Patches (VMAPs) Market Value by Form of Use (US$ Million), 2025 vs 2032
Table 4. Global Vaccine Microarray Patches (VMAPs) Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Vaccine Microarray Patches (VMAPs) Market Competitive Situation by Manufacturers in 2025
Table 6. Global Vaccine Microarray Patches (VMAPs) Sales (K Pcs) of Key Manufacturers (2021–2026)
Table 7. Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Vaccine Microarray Patches (VMAPs) Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Vaccine Microarray Patches (VMAPs) Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Vaccine Microarray Patches (VMAPs) Average Price (US$/Pc) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Vaccine Microarray Patches (VMAPs), Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Vaccine Microarray Patches (VMAPs), Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Vaccine Microarray Patches (VMAPs), Product Types and Applications
Table 14. Global Key Manufacturers of Vaccine Microarray Patches (VMAPs), Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Vaccine Microarray Patches (VMAPs) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Vaccine Microarray Patches (VMAPs) Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Vaccine Microarray Patches (VMAPs) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Vaccine Microarray Patches (VMAPs) Sales by Region (K Pcs), 2021–2026
Table 20. Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Region (2021–2026)
Table 21. Global Vaccine Microarray Patches (VMAPs) Sales by Region (K Pcs), 2027–2032
Table 22. Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Region (2027–2032)
Table 23. Global Vaccine Microarray Patches (VMAPs) Revenue by Region (US$ Million), 2021–2026
Table 24. Global Vaccine Microarray Patches (VMAPs) Revenue Market Share by Region (2021–2026)
Table 25. Global Vaccine Microarray Patches (VMAPs) Revenue by Region (US$ Million), 2027–2032
Table 26. Global Vaccine Microarray Patches (VMAPs) Revenue Market Share by Region (2027–2032)
Table 27. North America Vaccine Microarray Patches (VMAPs) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Vaccine Microarray Patches (VMAPs) Sales by Country (K Pcs), 2021–2026
Table 29. North America Vaccine Microarray Patches (VMAPs) Sales by Country (K Pcs), 2027–2032
Table 30. North America Vaccine Microarray Patches (VMAPs) Revenue by Country (US$ Million), 2021–2026
Table 31. North America Vaccine Microarray Patches (VMAPs) Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Vaccine Microarray Patches (VMAPs) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Vaccine Microarray Patches (VMAPs) Sales by Country (K Pcs), 2021–2026
Table 34. Europe Vaccine Microarray Patches (VMAPs) Sales by Country (K Pcs), 2027–2032
Table 35. Europe Vaccine Microarray Patches (VMAPs) Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Vaccine Microarray Patches (VMAPs) Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Vaccine Microarray Patches (VMAPs) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Vaccine Microarray Patches (VMAPs) Sales by Region (K Pcs), 2021–2026
Table 39. Asia Pacific Vaccine Microarray Patches (VMAPs) Sales by Region (K Pcs), 2027–2032
Table 40. Asia Pacific Vaccine Microarray Patches (VMAPs) Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Vaccine Microarray Patches (VMAPs) Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Vaccine Microarray Patches (VMAPs) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Vaccine Microarray Patches (VMAPs) Sales by Country (K Pcs), 2021–2026
Table 44. Latin America Vaccine Microarray Patches (VMAPs) Sales by Country (K Pcs), 2027–2032
Table 45. Latin America Vaccine Microarray Patches (VMAPs) Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Vaccine Microarray Patches (VMAPs) Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Vaccine Microarray Patches (VMAPs) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Vaccine Microarray Patches (VMAPs) Sales by Country (K Pcs), 2021–2026
Table 49. Middle East and Africa Vaccine Microarray Patches (VMAPs) Sales by Country (K Pcs), 2027–2032
Table 50. Middle East and Africa Vaccine Microarray Patches (VMAPs) Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Vaccine Microarray Patches (VMAPs) Revenue by Country (US$ Million), 2027–2032
Table 52. Global Vaccine Microarray Patches (VMAPs) Sales (K Pcs) by Type (2021–2026)
Table 53. Global Vaccine Microarray Patches (VMAPs) Sales (K Pcs) by Type (2027–2032)
Table 54. Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Type (2021–2026)
Table 55. Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Type (2027–2032)
Table 56. Global Vaccine Microarray Patches (VMAPs) Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Vaccine Microarray Patches (VMAPs) Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Vaccine Microarray Patches (VMAPs) Revenue Market Share by Type (2021–2026)
Table 59. Global Vaccine Microarray Patches (VMAPs) Revenue Market Share by Type (2027–2032)
Table 60. Global Vaccine Microarray Patches (VMAPs) Price (US$/Pc) by Type (2021–2026)
Table 61. Global Vaccine Microarray Patches (VMAPs) Price (US$/Pc) by Type (2027–2032)
Table 62. Global Vaccine Microarray Patches (VMAPs) Sales (K Pcs) by Application (2021–2026)
Table 63. Global Vaccine Microarray Patches (VMAPs) Sales (K Pcs) by Application (2027–2032)
Table 64. Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Application (2021–2026)
Table 65. Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Application (2027–2032)
Table 66. Global Vaccine Microarray Patches (VMAPs) Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Vaccine Microarray Patches (VMAPs) Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Vaccine Microarray Patches (VMAPs) Revenue Market Share by Application (2021–2026)
Table 69. Global Vaccine Microarray Patches (VMAPs) Revenue Market Share by Application (2027–2032)
Table 70. Global Vaccine Microarray Patches (VMAPs) Price (US$/Pc) by Application (2021–2026)
Table 71. Global Vaccine Microarray Patches (VMAPs) Price (US$/Pc) by Application (2027–2032)
Table 72. Kindeva Company Information
Table 73. Kindeva Description and Business Overview
Table 74. Kindeva Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 75. Kindeva Vaccine Microarray Patches (VMAPs) Product
Table 76. Kindeva Recent Developments/Updates
Table 77. Raphas Company Information
Table 78. Raphas Description and Business Overview
Table 79. Raphas Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 80. Raphas Vaccine Microarray Patches (VMAPs) Product
Table 81. Raphas Recent Developments/Updates
Table 82. CosMED Pharmaceutical Company Information
Table 83. CosMED Pharmaceutical Description and Business Overview
Table 84. CosMED Pharmaceutical Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 85. CosMED Pharmaceutical Vaccine Microarray Patches (VMAPs) Product
Table 86. CosMED Pharmaceutical Recent Developments/Updates
Table 87. Vaxess Technologies Company Information
Table 88. Vaxess Technologies Description and Business Overview
Table 89. Vaxess Technologies Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 90. Vaxess Technologies Vaccine Microarray Patches (VMAPs) Product
Table 91. Vaxess Technologies Recent Developments/Updates
Table 92. Micron Biomedical Company Information
Table 93. Micron Biomedical Description and Business Overview
Table 94. Micron Biomedical Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 95. Micron Biomedical Vaccine Microarray Patches (VMAPs) Product
Table 96. Micron Biomedical Recent Developments/Updates
Table 97. LTS Lohmann Therapie-Systeme Company Information
Table 98. LTS Lohmann Therapie-Systeme Description and Business Overview
Table 99. LTS Lohmann Therapie-Systeme Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 100. LTS Lohmann Therapie-Systeme Vaccine Microarray Patches (VMAPs) Product
Table 101. LTS Lohmann Therapie-Systeme Recent Developments/Updates
Table 102. ArrayPatch Company Information
Table 103. ArrayPatch Description and Business Overview
Table 104. ArrayPatch Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 105. ArrayPatch Vaccine Microarray Patches (VMAPs) Product
Table 106. ArrayPatch Recent Developments/Updates
Table 107. CeraVx Company Information
Table 108. CeraVx Description and Business Overview
Table 109. CeraVx Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 110. CeraVx Vaccine Microarray Patches (VMAPs) Product
Table 111. CeraVx Recent Developments/Updates
Table 112. Zhongke Microneedle (Beijing) Technology Company Information
Table 113. Zhongke Microneedle (Beijing) Technology Description and Business Overview
Table 114. Zhongke Microneedle (Beijing) Technology Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 115. Zhongke Microneedle (Beijing) Technology Vaccine Microarray Patches (VMAPs) Product
Table 116. Zhongke Microneedle (Beijing) Technology Recent Developments/Updates
Table 117. Zhuhai Youwe Biotechnology Company Information
Table 118. Zhuhai Youwe Biotechnology Description and Business Overview
Table 119. Zhuhai Youwe Biotechnology Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 120. Zhuhai Youwe Biotechnology Vaccine Microarray Patches (VMAPs) Product
Table 121. Zhuhai Youwe Biotechnology Recent Developments/Updates
Table 122. Youwei (Zhuhai) Biotechnology Company Information
Table 123. Youwei (Zhuhai) Biotechnology Description and Business Overview
Table 124. Youwei (Zhuhai) Biotechnology Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 125. Youwei (Zhuhai) Biotechnology Vaccine Microarray Patches (VMAPs) Product
Table 126. Youwei (Zhuhai) Biotechnology Recent Developments/Updates
Table 127. WCC Biomedical Company Information
Table 128. WCC Biomedical Description and Business Overview
Table 129. WCC Biomedical Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 130. WCC Biomedical Vaccine Microarray Patches (VMAPs) Product
Table 131. WCC Biomedical Recent Developments/Updates
Table 132. Hisamitsu Pharmaceutical Company Information
Table 133. Hisamitsu Pharmaceutical Description and Business Overview
Table 134. Hisamitsu Pharmaceutical Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 135. Hisamitsu Pharmaceutical Vaccine Microarray Patches (VMAPs) Product
Table 136. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Vaccine Microarray Patches (VMAPs) Distributors List
Table 140. Vaccine Microarray Patches (VMAPs) Customers List
Table 141. Vaccine Microarray Patches (VMAPs) Market Trends
Table 142. Vaccine Microarray Patches (VMAPs) Market Drivers
Table 143. Vaccine Microarray Patches (VMAPs) Market Challenges
Table 144. Vaccine Microarray Patches (VMAPs) Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
Table 148. Authors List of This Report
List of Figures
Figure 1. Product Picture of Vaccine Microarray Patches (VMAPs)
Figure 2. Global Vaccine Microarray Patches (VMAPs) Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Vaccine Microarray Patches (VMAPs) Market Share by Type: 2025 & 2032
Figure 4. Dissolving Product Picture
Figure 5. Non-dissolving Product Picture
Figure 6. Global Vaccine Microarray Patches (VMAPs) Market Value by Microneedle Material (US$ Million), 2021–2032
Figure 7. Global Vaccine Microarray Patches (VMAPs) Market Share by Microneedle Material: 2025 vs 2032
Figure 8. Hyaluronic Acid Product Picture
Figure 9. Taurine Product Picture
Figure 10. Triple-helical Collagen Product Picture
Figure 11. Global Vaccine Microarray Patches (VMAPs) Market Value by Form of Use (US$ Million), 2021–2032
Figure 12. Global Vaccine Microarray Patches (VMAPs) Market Share by Form of Use: 2025 vs 2032
Figure 13. Patches Product Picture
Figure 14. Direct Topical Product Picture
Figure 15. Global Vaccine Microarray Patches (VMAPs) Market Value by Application (US$ Million), 2021–2032
Figure 16. Global Vaccine Microarray Patches (VMAPs) Market Share by Application: 2025 & 2032
Figure 17. Routine Childhood Immunization
Figure 18. Adolescent / Pre-adolescent Prevention
Figure 19. Travel / Endemic Exposure / Post-exposure
Figure 20. Respiratory Vaccines with Recurring Demand
Figure 21. Outbreak / Pandemic Preparedness
Figure 22. Global Vaccine Microarray Patches (VMAPs) Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Vaccine Microarray Patches (VMAPs) Market Size (US$ Million), 2021–2032
Figure 24. Global Vaccine Microarray Patches (VMAPs) Sales (K Pcs), 2021–2032
Figure 25. Global Vaccine Microarray Patches (VMAPs) Average Price (US$/Pc), 2021–2032
Figure 26. Vaccine Microarray Patches (VMAPs) Report Years Considered
Figure 27. Vaccine Microarray Patches (VMAPs) Sales Share by Manufacturers in 2025
Figure 28. Global Vaccine Microarray Patches (VMAPs) Revenue Share by Manufacturers in 2025
Figure 29. Top 5 and Top 10 Global Vaccine Microarray Patches (VMAPs) Players: Market Share by Revenue in Vaccine Microarray Patches (VMAPs) in 2025
Figure 30. Vaccine Microarray Patches (VMAPs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 31. Global Vaccine Microarray Patches (VMAPs) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 32. North America Vaccine Microarray Patches (VMAPs) Sales Market Share by Country (2021–2032)
Figure 33. North America Vaccine Microarray Patches (VMAPs) Revenue Market Share by Country (2021–2032)
Figure 34. United States Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Canada Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Europe Vaccine Microarray Patches (VMAPs) Sales Market Share by Country (2021–2032)
Figure 37. Europe Vaccine Microarray Patches (VMAPs) Revenue Market Share by Country (2021–2032)
Figure 38. Germany Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. France Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. U.K. Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Italy Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Russia Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Asia Pacific Vaccine Microarray Patches (VMAPs) Sales Market Share by Region (2021–2032)
Figure 44. Asia Pacific Vaccine Microarray Patches (VMAPs) Revenue Market Share by Region (2021–2032)
Figure 45. China Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Japan Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. South Korea Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. India Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Australia Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. China Taiwan Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Southeast Asia Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Latin America Vaccine Microarray Patches (VMAPs) Sales Market Share by Country (2021–2032)
Figure 53. Latin America Vaccine Microarray Patches (VMAPs) Revenue Market Share by Country (2021–2032)
Figure 54. Mexico Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Brazil Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Argentina Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Colombia Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Middle East and Africa Vaccine Microarray Patches (VMAPs) Sales Market Share by Country (2021–2032)
Figure 59. Middle East and Africa Vaccine Microarray Patches (VMAPs) Revenue Market Share by Country (2021–2032)
Figure 60. Turkey Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Saudi Arabia Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. UAE Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Global Sales Market Share of Vaccine Microarray Patches (VMAPs) by Type (2021–2032)
Figure 64. Global Revenue Market Share of Vaccine Microarray Patches (VMAPs) by Type (2021–2032)
Figure 65. Global Vaccine Microarray Patches (VMAPs) Price (US$/Pc) by Type (2021–2032)
Figure 66. Global Sales Market Share of Vaccine Microarray Patches (VMAPs) by Application (2021–2032)
Figure 67. Global Revenue Market Share of Vaccine Microarray Patches (VMAPs) by Application (2021–2032)
Figure 68. Global Vaccine Microarray Patches (VMAPs) Price (US$/Pc) by Application (2021–2032)
Figure 69. Vaccine Microarray Patches (VMAPs) Value Chain
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Table 1. Global Vaccine Microarray Patches (VMAPs) Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Vaccine Microarray Patches (VMAPs) Market Value by Microneedle Material (US$ Million), 2025 vs 2032
Table 3. Global Vaccine Microarray Patches (VMAPs) Market Value by Form of Use (US$ Million), 2025 vs 2032
Table 4. Global Vaccine Microarray Patches (VMAPs) Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Vaccine Microarray Patches (VMAPs) Market Competitive Situation by Manufacturers in 2025
Table 6. Global Vaccine Microarray Patches (VMAPs) Sales (K Pcs) of Key Manufacturers (2021–2026)
Table 7. Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Vaccine Microarray Patches (VMAPs) Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Vaccine Microarray Patches (VMAPs) Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Vaccine Microarray Patches (VMAPs) Average Price (US$/Pc) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Vaccine Microarray Patches (VMAPs), Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Vaccine Microarray Patches (VMAPs), Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Vaccine Microarray Patches (VMAPs), Product Types and Applications
Table 14. Global Key Manufacturers of Vaccine Microarray Patches (VMAPs), Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Vaccine Microarray Patches (VMAPs) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Vaccine Microarray Patches (VMAPs) Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Vaccine Microarray Patches (VMAPs) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Vaccine Microarray Patches (VMAPs) Sales by Region (K Pcs), 2021–2026
Table 20. Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Region (2021–2026)
Table 21. Global Vaccine Microarray Patches (VMAPs) Sales by Region (K Pcs), 2027–2032
Table 22. Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Region (2027–2032)
Table 23. Global Vaccine Microarray Patches (VMAPs) Revenue by Region (US$ Million), 2021–2026
Table 24. Global Vaccine Microarray Patches (VMAPs) Revenue Market Share by Region (2021–2026)
Table 25. Global Vaccine Microarray Patches (VMAPs) Revenue by Region (US$ Million), 2027–2032
Table 26. Global Vaccine Microarray Patches (VMAPs) Revenue Market Share by Region (2027–2032)
Table 27. North America Vaccine Microarray Patches (VMAPs) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Vaccine Microarray Patches (VMAPs) Sales by Country (K Pcs), 2021–2026
Table 29. North America Vaccine Microarray Patches (VMAPs) Sales by Country (K Pcs), 2027–2032
Table 30. North America Vaccine Microarray Patches (VMAPs) Revenue by Country (US$ Million), 2021–2026
Table 31. North America Vaccine Microarray Patches (VMAPs) Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Vaccine Microarray Patches (VMAPs) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Vaccine Microarray Patches (VMAPs) Sales by Country (K Pcs), 2021–2026
Table 34. Europe Vaccine Microarray Patches (VMAPs) Sales by Country (K Pcs), 2027–2032
Table 35. Europe Vaccine Microarray Patches (VMAPs) Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Vaccine Microarray Patches (VMAPs) Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Vaccine Microarray Patches (VMAPs) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Vaccine Microarray Patches (VMAPs) Sales by Region (K Pcs), 2021–2026
Table 39. Asia Pacific Vaccine Microarray Patches (VMAPs) Sales by Region (K Pcs), 2027–2032
Table 40. Asia Pacific Vaccine Microarray Patches (VMAPs) Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Vaccine Microarray Patches (VMAPs) Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Vaccine Microarray Patches (VMAPs) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Vaccine Microarray Patches (VMAPs) Sales by Country (K Pcs), 2021–2026
Table 44. Latin America Vaccine Microarray Patches (VMAPs) Sales by Country (K Pcs), 2027–2032
Table 45. Latin America Vaccine Microarray Patches (VMAPs) Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Vaccine Microarray Patches (VMAPs) Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Vaccine Microarray Patches (VMAPs) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Vaccine Microarray Patches (VMAPs) Sales by Country (K Pcs), 2021–2026
Table 49. Middle East and Africa Vaccine Microarray Patches (VMAPs) Sales by Country (K Pcs), 2027–2032
Table 50. Middle East and Africa Vaccine Microarray Patches (VMAPs) Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Vaccine Microarray Patches (VMAPs) Revenue by Country (US$ Million), 2027–2032
Table 52. Global Vaccine Microarray Patches (VMAPs) Sales (K Pcs) by Type (2021–2026)
Table 53. Global Vaccine Microarray Patches (VMAPs) Sales (K Pcs) by Type (2027–2032)
Table 54. Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Type (2021–2026)
Table 55. Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Type (2027–2032)
Table 56. Global Vaccine Microarray Patches (VMAPs) Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Vaccine Microarray Patches (VMAPs) Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Vaccine Microarray Patches (VMAPs) Revenue Market Share by Type (2021–2026)
Table 59. Global Vaccine Microarray Patches (VMAPs) Revenue Market Share by Type (2027–2032)
Table 60. Global Vaccine Microarray Patches (VMAPs) Price (US$/Pc) by Type (2021–2026)
Table 61. Global Vaccine Microarray Patches (VMAPs) Price (US$/Pc) by Type (2027–2032)
Table 62. Global Vaccine Microarray Patches (VMAPs) Sales (K Pcs) by Application (2021–2026)
Table 63. Global Vaccine Microarray Patches (VMAPs) Sales (K Pcs) by Application (2027–2032)
Table 64. Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Application (2021–2026)
Table 65. Global Vaccine Microarray Patches (VMAPs) Sales Market Share by Application (2027–2032)
Table 66. Global Vaccine Microarray Patches (VMAPs) Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Vaccine Microarray Patches (VMAPs) Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Vaccine Microarray Patches (VMAPs) Revenue Market Share by Application (2021–2026)
Table 69. Global Vaccine Microarray Patches (VMAPs) Revenue Market Share by Application (2027–2032)
Table 70. Global Vaccine Microarray Patches (VMAPs) Price (US$/Pc) by Application (2021–2026)
Table 71. Global Vaccine Microarray Patches (VMAPs) Price (US$/Pc) by Application (2027–2032)
Table 72. Kindeva Company Information
Table 73. Kindeva Description and Business Overview
Table 74. Kindeva Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 75. Kindeva Vaccine Microarray Patches (VMAPs) Product
Table 76. Kindeva Recent Developments/Updates
Table 77. Raphas Company Information
Table 78. Raphas Description and Business Overview
Table 79. Raphas Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 80. Raphas Vaccine Microarray Patches (VMAPs) Product
Table 81. Raphas Recent Developments/Updates
Table 82. CosMED Pharmaceutical Company Information
Table 83. CosMED Pharmaceutical Description and Business Overview
Table 84. CosMED Pharmaceutical Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 85. CosMED Pharmaceutical Vaccine Microarray Patches (VMAPs) Product
Table 86. CosMED Pharmaceutical Recent Developments/Updates
Table 87. Vaxess Technologies Company Information
Table 88. Vaxess Technologies Description and Business Overview
Table 89. Vaxess Technologies Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 90. Vaxess Technologies Vaccine Microarray Patches (VMAPs) Product
Table 91. Vaxess Technologies Recent Developments/Updates
Table 92. Micron Biomedical Company Information
Table 93. Micron Biomedical Description and Business Overview
Table 94. Micron Biomedical Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 95. Micron Biomedical Vaccine Microarray Patches (VMAPs) Product
Table 96. Micron Biomedical Recent Developments/Updates
Table 97. LTS Lohmann Therapie-Systeme Company Information
Table 98. LTS Lohmann Therapie-Systeme Description and Business Overview
Table 99. LTS Lohmann Therapie-Systeme Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 100. LTS Lohmann Therapie-Systeme Vaccine Microarray Patches (VMAPs) Product
Table 101. LTS Lohmann Therapie-Systeme Recent Developments/Updates
Table 102. ArrayPatch Company Information
Table 103. ArrayPatch Description and Business Overview
Table 104. ArrayPatch Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 105. ArrayPatch Vaccine Microarray Patches (VMAPs) Product
Table 106. ArrayPatch Recent Developments/Updates
Table 107. CeraVx Company Information
Table 108. CeraVx Description and Business Overview
Table 109. CeraVx Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 110. CeraVx Vaccine Microarray Patches (VMAPs) Product
Table 111. CeraVx Recent Developments/Updates
Table 112. Zhongke Microneedle (Beijing) Technology Company Information
Table 113. Zhongke Microneedle (Beijing) Technology Description and Business Overview
Table 114. Zhongke Microneedle (Beijing) Technology Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 115. Zhongke Microneedle (Beijing) Technology Vaccine Microarray Patches (VMAPs) Product
Table 116. Zhongke Microneedle (Beijing) Technology Recent Developments/Updates
Table 117. Zhuhai Youwe Biotechnology Company Information
Table 118. Zhuhai Youwe Biotechnology Description and Business Overview
Table 119. Zhuhai Youwe Biotechnology Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 120. Zhuhai Youwe Biotechnology Vaccine Microarray Patches (VMAPs) Product
Table 121. Zhuhai Youwe Biotechnology Recent Developments/Updates
Table 122. Youwei (Zhuhai) Biotechnology Company Information
Table 123. Youwei (Zhuhai) Biotechnology Description and Business Overview
Table 124. Youwei (Zhuhai) Biotechnology Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 125. Youwei (Zhuhai) Biotechnology Vaccine Microarray Patches (VMAPs) Product
Table 126. Youwei (Zhuhai) Biotechnology Recent Developments/Updates
Table 127. WCC Biomedical Company Information
Table 128. WCC Biomedical Description and Business Overview
Table 129. WCC Biomedical Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 130. WCC Biomedical Vaccine Microarray Patches (VMAPs) Product
Table 131. WCC Biomedical Recent Developments/Updates
Table 132. Hisamitsu Pharmaceutical Company Information
Table 133. Hisamitsu Pharmaceutical Description and Business Overview
Table 134. Hisamitsu Pharmaceutical Vaccine Microarray Patches (VMAPs) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 135. Hisamitsu Pharmaceutical Vaccine Microarray Patches (VMAPs) Product
Table 136. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Vaccine Microarray Patches (VMAPs) Distributors List
Table 140. Vaccine Microarray Patches (VMAPs) Customers List
Table 141. Vaccine Microarray Patches (VMAPs) Market Trends
Table 142. Vaccine Microarray Patches (VMAPs) Market Drivers
Table 143. Vaccine Microarray Patches (VMAPs) Market Challenges
Table 144. Vaccine Microarray Patches (VMAPs) Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
Table 148. Authors List of This Report
List of Figures
Figure 1. Product Picture of Vaccine Microarray Patches (VMAPs)
Figure 2. Global Vaccine Microarray Patches (VMAPs) Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Vaccine Microarray Patches (VMAPs) Market Share by Type: 2025 & 2032
Figure 4. Dissolving Product Picture
Figure 5. Non-dissolving Product Picture
Figure 6. Global Vaccine Microarray Patches (VMAPs) Market Value by Microneedle Material (US$ Million), 2021–2032
Figure 7. Global Vaccine Microarray Patches (VMAPs) Market Share by Microneedle Material: 2025 vs 2032
Figure 8. Hyaluronic Acid Product Picture
Figure 9. Taurine Product Picture
Figure 10. Triple-helical Collagen Product Picture
Figure 11. Global Vaccine Microarray Patches (VMAPs) Market Value by Form of Use (US$ Million), 2021–2032
Figure 12. Global Vaccine Microarray Patches (VMAPs) Market Share by Form of Use: 2025 vs 2032
Figure 13. Patches Product Picture
Figure 14. Direct Topical Product Picture
Figure 15. Global Vaccine Microarray Patches (VMAPs) Market Value by Application (US$ Million), 2021–2032
Figure 16. Global Vaccine Microarray Patches (VMAPs) Market Share by Application: 2025 & 2032
Figure 17. Routine Childhood Immunization
Figure 18. Adolescent / Pre-adolescent Prevention
Figure 19. Travel / Endemic Exposure / Post-exposure
Figure 20. Respiratory Vaccines with Recurring Demand
Figure 21. Outbreak / Pandemic Preparedness
Figure 22. Global Vaccine Microarray Patches (VMAPs) Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Vaccine Microarray Patches (VMAPs) Market Size (US$ Million), 2021–2032
Figure 24. Global Vaccine Microarray Patches (VMAPs) Sales (K Pcs), 2021–2032
Figure 25. Global Vaccine Microarray Patches (VMAPs) Average Price (US$/Pc), 2021–2032
Figure 26. Vaccine Microarray Patches (VMAPs) Report Years Considered
Figure 27. Vaccine Microarray Patches (VMAPs) Sales Share by Manufacturers in 2025
Figure 28. Global Vaccine Microarray Patches (VMAPs) Revenue Share by Manufacturers in 2025
Figure 29. Top 5 and Top 10 Global Vaccine Microarray Patches (VMAPs) Players: Market Share by Revenue in Vaccine Microarray Patches (VMAPs) in 2025
Figure 30. Vaccine Microarray Patches (VMAPs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 31. Global Vaccine Microarray Patches (VMAPs) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 32. North America Vaccine Microarray Patches (VMAPs) Sales Market Share by Country (2021–2032)
Figure 33. North America Vaccine Microarray Patches (VMAPs) Revenue Market Share by Country (2021–2032)
Figure 34. United States Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Canada Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Europe Vaccine Microarray Patches (VMAPs) Sales Market Share by Country (2021–2032)
Figure 37. Europe Vaccine Microarray Patches (VMAPs) Revenue Market Share by Country (2021–2032)
Figure 38. Germany Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. France Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. U.K. Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Italy Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Russia Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Asia Pacific Vaccine Microarray Patches (VMAPs) Sales Market Share by Region (2021–2032)
Figure 44. Asia Pacific Vaccine Microarray Patches (VMAPs) Revenue Market Share by Region (2021–2032)
Figure 45. China Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Japan Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. South Korea Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. India Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Australia Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. China Taiwan Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Southeast Asia Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Latin America Vaccine Microarray Patches (VMAPs) Sales Market Share by Country (2021–2032)
Figure 53. Latin America Vaccine Microarray Patches (VMAPs) Revenue Market Share by Country (2021–2032)
Figure 54. Mexico Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Brazil Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Argentina Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Colombia Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Middle East and Africa Vaccine Microarray Patches (VMAPs) Sales Market Share by Country (2021–2032)
Figure 59. Middle East and Africa Vaccine Microarray Patches (VMAPs) Revenue Market Share by Country (2021–2032)
Figure 60. Turkey Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Saudi Arabia Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. UAE Vaccine Microarray Patches (VMAPs) Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Global Sales Market Share of Vaccine Microarray Patches (VMAPs) by Type (2021–2032)
Figure 64. Global Revenue Market Share of Vaccine Microarray Patches (VMAPs) by Type (2021–2032)
Figure 65. Global Vaccine Microarray Patches (VMAPs) Price (US$/Pc) by Type (2021–2032)
Figure 66. Global Sales Market Share of Vaccine Microarray Patches (VMAPs) by Application (2021–2032)
Figure 67. Global Revenue Market Share of Vaccine Microarray Patches (VMAPs) by Application (2021–2032)
Figure 68. Global Vaccine Microarray Patches (VMAPs) Price (US$/Pc) by Application (2021–2032)
Figure 69. Vaccine Microarray Patches (VMAPs) Value Chain
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Ethylene Oxide (EO) Market Research Report 2026
Jan 17, 26
Global Stem Cells Cryopreservation Equipments Market Research Report 2026
Jan 17, 26
Global Selenium-enriched Yeast Market Research Report 2026
Jan 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232